McKesson Secures New $2 Billion Senior Credit Facilities
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from McKesson ( (MCK) ).
On April 1, 2026, McKesson subsidiaries, including McKesson Medical-Surgical Top Holdings, entered into a new senior secured credit agreement totaling $2 billion, comprising a $750 million term loan A-1 due 2031, a $250 million term loan A-2 due 2028 and a $1 billion revolving credit facility maturing in 2031. The facilities, arranged with a syndicate of lenders led by JPMorgan Chase as administrative and collateral agent, are secured by substantially all tangible and intangible assets of the borrower and certain U.S. subsidiaries.
Borrowings under the term and revolving facilities will bear interest at SOFR- or base-rate benchmarks plus margins that adjust based on McKesson’s total net leverage and public credit ratings, and the company will also pay a commitment fee tied to these metrics. The credit agreement imposes customary covenants, including quarterly tests on maximum total net leverage and minimum interest coverage ratios, along with standard limits on additional indebtedness, liens, investments, asset sales and distributions, shaping McKesson’s future capital structure and financial flexibility.
The most recent analyst rating on (MCK) stock is a Buy with a $1000.00 price target. To see the full list of analyst forecasts on McKesson stock, see the MCK Stock Forecast page.
Spark’s Take on MCK Stock
According to Spark, TipRanks’ AI Analyst, MCK is a Outperform.
The score is driven by strong fundamentals and cash generation plus a notably upbeat earnings call with raised FY26 guidance and solid segment momentum. Offsetting factors are balance-sheet leverage/volatility and only moderate valuation support, while technicals indicate a constructive longer-term trend but near-term consolidation.
To see Spark’s full report on MCK stock, click here.
More about McKesson
McKesson Corporation operates through subsidiaries such as McKesson Medical-Surgical Top Holdings, Inc., providing medical-surgical supplies and related services across the U.S. healthcare system. The company functions as a major healthcare distributor and solutions provider, supporting hospitals, clinics and other care providers with logistics, products and financing arrangements.
Average Trading Volume: 765,457
Technical Sentiment Signal: Buy
Current Market Cap: $108.3B
Find detailed analytics on MCK stock on TipRanks’ Stock Analysis page.
